Helicobacter pylori infection, gastritis and gastric cancer: Overexpression of c-H-ras p21 is correlated with vascular endothelial growth factor expression and neovascularization in advanced gastric carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 12, 2000, Pages 1393-1399

  Kim, Young Bae ^a,b   Han, Jee Young ^a   Kim, Tae Sook ^a   Kim, Pum Soo ^a   Chu, Young Chae ^a  

^a Inha University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Advanced gastric carcinoma; Angiogenesis; c H ras gene product; Vascular endothelial growth factor

Indexed keywords

ANTIBODY; CD34 ANTIGEN; GENE PRODUCT; KI 67 ANTIGEN; PROTEIN P21; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; HRAS PROTEIN, HUMAN; LYMPHOKINE; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; ONCOGENE C H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; ADENOCARCINOMA; FEMALE; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS P21(RAS); STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034565381     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02358.x     Document Type: Article

References (37)

1. Tumor angiogenesis
2. Angiogenesis
3. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
4. Vascular endothelial growth factor is a secreted angiogenic mitogen
5. Vascular permeability factor, an endothelial cell mitogen related to PDGF
6. Review: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
7. Regulation of the expression of VEGF/VPF and its receptors: Role in tumor angiogenesis
8. Vascular permeability factor (VPF,VEGF) in tumor biology
9. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
10. Oncogenes as reducers of tumor angiogenesis
11. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
12. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
13. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
14. The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCa T cell lines is reduced by a farnesyl transferase inhibitor
15. ras oncogenes in human cancer: A review
16. ras genes
17. Oncogenes and cancer: The p21 ras genes
18. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers
19. Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer
20. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in gastric cancers
21. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia
22. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers
23. Enhanced expression of c-H-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization
24. H-ras oncogene product in human gastric carcinoma: Correlation with invasiveness, metastasis or prognosis
25. Tumors of the esophagus and stomach
26. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for turmorigenicity of human colorectal carcinoma cells
27. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma
28. Review: Optimizing immunohistochemistry: Antigen retrieval and signal amplication
29. Intratumor microvessel density as a prognostic factor in cancer
30. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma
31. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: Correlation with Gleason's score, microvessel density, and epithelial cell proliferation
32. Endothelial proliferation in tumours and normal tissues: Continuous labeling studies
33. Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
34. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma
35. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
36. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma
37. Critical factors controlling angiogenesis: Cell products, cell matrix, and growth factors